Key TakeawaysLife sciences clinical researcher IQVIA's second-quarter results beat analysts' expectations for revenue and net income.The company also raised its full-year guidance.IQVIA said its technology and analytics products were major growth drivers.IQVIA's stock rose nearly 7% in intraday trading Monday to move into positive territory for the year. IQVIA Holdings (IQV) beat second-quarter earnings expectations and raised its full-year outlook on Monday, sending shares higher. The life sciences clinica ...